Covered recipient · General Payments record
MERLA PURAY
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$9,706.68
- Reported across 430 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,236.36 | 53 |
| Education | $199.90 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $160.13 | 11 |
| Acerta Pharma LLC | $142.05 | 3 |
| Astellas Pharma US Inc | $132.67 | 3 |
| AVEO Pharmaceuticals, Inc. | $126.24 | 2 |
| Merck Sharp & Dohme Corporation | $123.81 | 5 |
| Takeda Pharmaceuticals U.S.A., Inc. | $73.64 | 3 |
| Gilead Sciences, Inc. | $72.35 | 4 |
| Mirati Therapeutics, Inc. | $71.11 | 3 |
| GENZYME CORPORATION | $59.16 | 2 |
| Exelixis Inc. | $58.52 | 2 |
| E.R. Squibb & Sons, L.L.C. | $57.88 | 2 |
| EISAI INC. | $57.61 | 2 |
| Daiichi Sankyo Inc. | $48.95 | 2 |
| SOBI, INC | $46.91 | 2 |
| ADC Therapeutics America, Inc. | $33.73 | 1 |
| PharmaEssentia USA Corporation | $27.78 | 1 |
| Lilly USA, LLC | $24.15 | 1 |
| BeiGene USA, Inc. | $22.93 | 1 |
| TAIHO ONCOLOGY, INC. | $22.85 | 1 |
| ACCORD HEALTHCARE, INC. | $20.53 | 1 |
| Myriad Genetic Laboratories, Inc. | $19.96 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.23 | 1 |
| MorphoSys, US Inc. | $14.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (55)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.